Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16,846 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial.
Lv X, Cao X, Xia WX, Liu KY, Qiang MY, Guo L, Qian CN, Cao KJ, Mo HY, Li XM, Li ZH, Han F, He YX, Liu YM, Wu SX, Bai YR, Ke LR, Qiu WZ, Liang H, Liu GY, Miao JJ, Li WZ, Lv SH, Chen X, Zhao C, Xiang YQ, Guo X. Lv X, et al. Among authors: cao kj, cao x. Lancet Oncol. 2021 May;22(5):716-726. doi: 10.1016/S1470-2045(21)00075-9. Epub 2021 Apr 12. Lancet Oncol. 2021. PMID: 33857411 Clinical Trial.
Short-term efficacy and long-term survival of nasopharyngeal carcinoma patients with radiographically visible residual disease following observation or additional intervention: A real-world study in China.
Huang YY, Cao X, Cai ZC, Zhou JY, Guo X, Lv X. Huang YY, et al. Among authors: cao x. Laryngoscope Investig Otolaryngol. 2022 Nov 16;7(6):1881-1892. doi: 10.1002/lio2.980. eCollection 2022 Dec. Laryngoscope Investig Otolaryngol. 2022. PMID: 36544919 Free PMC article.
Tumor residue in patients with stage II-IVA nasopharyngeal carcinoma who received intensity-modulated radiation therapy: development and validation of a prediction nomogram integrating postradiotherapy plasma Epstein-Barr virus deoxyribonucleic acid, clinical stage, and radiotherapy dose.
Huang YY, Zhou JY, Zhan ZJ, Ke LR, Xia WX, Cao X, Cai ZC, Deng Y, Chen X, Zhang LL, Huang HY, Guo X, Lv X. Huang YY, et al. Among authors: cao x. BMC Cancer. 2023 May 6;23(1):410. doi: 10.1186/s12885-023-10827-0. BMC Cancer. 2023. PMID: 37149594 Free PMC article.
16,846 results
You have reached the last available page of results. Please see the User Guide for more information.